Research

Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study

Nick A Francis, Phillip D Monk, Jacqueline Nuttall, Thomas Oliver, Catherine Simpson, Jody L Brookes, Victoria J Tear, Angela G Thompson, Toby N Batten, Marcin Mankowski and Thomas MA Wilkinson
BJGP Open 2023; 7 (4): BJGPO.2023.0089. DOI: https://doi.org/10.3399/BJGPO.2023.0089
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com. PLEASE NOTE: your email address will be published.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

BJGP Open
Vol. 7, Issue 4
December 2023
Download PDF
Download PowerPoint
Email Article
Citation Tools
Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study
Nick A Francis, Phillip D Monk, Jacqueline Nuttall, Thomas Oliver, Catherine Simpson, Jody L Brookes, Victoria J Tear, Angela G Thompson, Toby N Batten, Marcin Mankowski, Thomas MA Wilkinson
BJGP Open 2023; 7 (4): BJGPO.2023.0089. DOI: 10.3399/BJGPO.2023.0089
del.icio.us logo Facebook logo Mendeley logo

Jump to section

Keywords

Intended for Healthcare Professionals
 
 

British Journal of General Practice